Japan Pharmaceutical 3PL Market Size (2024 - 2029)

The Japan Pharmaceutical 3PL Market is experiencing growth driven by the increasing adoption of online delivery services and the demand for third-party logistics solutions. The country's leadership in this market is supported by government incentives and collaborative efforts between regulatory agencies and pharmaceutical companies to enhance information exchange and patient services. The expansion of temperature-controlled logistics for biologics and the distribution networks of biopharmaceutical companies are key factors contributing to the market's growth. Additionally, the use of automated storage and retrieval systems is rising, particularly in emerging nations, as major players focus on minimizing supply disruptions and prioritizing essential treatments.

Home Market Analysis Logistics Research Integrated Logistics Research 3PL Research Pharmaceutical 3PL Research Japan 3PL Pharmaceutical Logistics Market Market Size

Market Size of Japan Pharmaceutical 3PL Industry

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:
Japan pharmaceutical 3PL market size
Study Period 2019 - 2029
Base Year For Estimation 2023
Market Size (2024) USD 67.41 Billion
Market Size (2029) USD 94.37 Billion
CAGR (2024 - 2029) 7.00 %
Market Concentration Low

Major Players

Japan Pharmaceutical 3PL Market Major Players

*Disclaimer: Major Players sorted in no particular order

Need a report that reflects how COVID-19 has impacted this market and its growth?

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Japan Pharmaceutical 3PL Market Analysis

The Japan Pharmaceutical 3PL Market size is estimated at USD 67.41 billion in 2024, and is expected to reach USD 94.37 billion by 2029, growing at a CAGR of 7% during the forecast period (2024-2029).

  • The pharmaceutical industry's third-party logistics market is growing because more and more people are willing to use online delivery services. This trend has led to a rise in demand for third-party logistics solutions. Japan has been the leading force in the pharmaceutical third-party logistics market, with the government providing incentives. The Japanese Pharmaceutical and Medical Devices Agency, in partnership with the Japanese Ministry of Health, Labour, and Welfare and drug companies, created a platform for online information exchange and patient consultation services.
  • The demand for temperature-controlled logistics services to ship biologics across international borders and the expansion of biopharmaceutical companies' distribution networks to boost sales are fueling market expansion. It serves as motivation. Pharmaceutical logistics organizations have noticed a considerable increase in the use of automated storage and retrieval systems in emerging nations. By limiting supply disruptions and giving priority to crucial treatments, major market actors played a significant role in the fight against COVID-19.
  • For example, Nippon Express has WHO Standard GDP Certification for the East Japan Pharmaceutical Center in Kuki, Saitama Prefecture. This is because they focus on storage and transit with two temperature zones to meet the demand for high-quality logistics. The center has WHO (World Health Organization) standard GDP certification for storing and transporting medications in two temperature zones (room temperature: 15-25°C, cold storage: 2-8°C).

Japan Pharmaceutical 3PL Industry Segmentation

The report quantifies the size of the Japanese pharmaceutical 3PL market. The report offers a thorough background analysis of the Japan pharmaceutical 3PL market, covering the most recent technology advancements, market trends, and in-depth details on key market segments and the industry's competitive environment. The analysis has also incorporated and taken into account the COVID-19 impact.

The Japan pharmaceutical 3PL market is segmented by service (domestic transportation management, international transportation management, and value-added warehousing and distribution) and by temperature control (controlled/cold chain logistics vs. non-controlled/non-cold chain logistics). The report offers market size and forecasts for the Japan pharmaceutical 3PL market in terms of value (USD) for all the above segments.

By Service
Domestic Transportation Management
International Transportation Management
Value-added Warehousing and Distribution
By Temperature Control
Controlled/Cold Chain Logistics
Non-controlled/Non-Cold Chain Logistics
Need A Different Region Or Segment?
Customize Now

Japan Pharmaceutical 3PL Market Size Summary

The pharmaceutical third-party logistics (3PL) market in Japan is experiencing significant growth, driven by the increasing demand for online delivery services and the need for specialized logistics solutions. The Japanese government, in collaboration with the Japanese Pharmaceutical and Medical Devices Agency and the Ministry of Health, Labour, and Welfare, has been proactive in creating platforms for online information exchange and patient consultation services, further boosting the market. The expansion of biopharmaceutical companies' distribution networks and the demand for temperature-controlled logistics services to transport biologics internationally are key factors propelling market growth. Major players in the industry, such as Nippon Express, are enhancing their capabilities with certifications like the WHO Standard GDP Certification, ensuring high-quality logistics services that meet stringent storage and transit requirements.

The Japanese pharmaceutical market is also witnessing a rapid expansion in the generic drug segment, driven by an aging population and rising healthcare costs. Government policies aimed at increasing generic medicine penetration have led to a significant rise in the use of generics, making them a viable option for cost-conscious consumers. Despite Japan's historically lower penetration of generics compared to other developed markets, recent policy changes have spurred growth in this area. The country's pharmaceutical industry, part of the broader economic revival strategy, continues to attract interest, particularly in the wake of the COVID-19 pandemic, which underscored the importance of innovative healthcare solutions. The competitive landscape of the pharmaceutical 3PL market in Japan is characterized by a few key players, including DHL Logistics, Nippon Express, Kuehne + Nagel, and Kerry Logistics, who leverage advanced technology and specialized storage facilities to maintain their market positions.

Explore More

Japan Pharmaceutical 3PL Market Size - Table of Contents

  1. 1. MARKET INSIGHTS

    1. 1.1 Market Overview

    2. 1.2 Current Market Scenario

    3. 1.3 Government Initiatives and Regulations

    4. 1.4 Technological Trends

    5. 1.5 Industry Supply Chain/Value Chain Analysis

    6. 1.6 Investment Scenarios

    7. 1.7 Pharmaceutical E-Commerce Market in Japan

    8. 1.8 Spotlight on packaging of pharmaceuticals (global and regional trends)

    9. 1.9 Impact of COVID-19 on market (including short-term and long-term effects on the market as well as the economy)

  2. 2. MARKET SEGMENTATION

    1. 2.1 By Service

      1. 2.1.1 Domestic Transportation Management

      2. 2.1.2 International Transportation Management

      3. 2.1.3 Value-added Warehousing and Distribution

    2. 2.2 By Temperature Control

      1. 2.2.1 Controlled/Cold Chain Logistics

      2. 2.2.2 Non-controlled/Non-Cold Chain Logistics

Japan Pharmaceutical 3PL Market Size FAQs

The Japan Pharmaceutical 3PL Market size is expected to reach USD 67.41 billion in 2024 and grow at a CAGR of 7% to reach USD 94.37 billion by 2029.

In 2024, the Japan Pharmaceutical 3PL Market size is expected to reach USD 67.41 billion.

Japan Pharmaceutical 3PL Market Report Snapshots

Japan Pharmaceutical 3PL Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)